Important pharmacy news and late-breaking industry information updated daily.
Safety violations at a major compounding pharmacy are exacerbating hospital shortages of opioid analgesics, particularly in California where health officials have prohibited sales from one of its plants. In late March, California's Board of Pharmacy barred the distribution of medications from a Texas factory belonging to the company, PharMEDium.
Pharmacist-led comprehensive medication management may be the solution
FDA on Friday issued a new <a href="https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatory…; target="_blank">guidance</a> to clarify that dietary supplements containing pure or highly concentrated caffeine in powder or liquid forms are considered unlawful when sold in bulk quantities directly to consumers.
Policy makers speak highly of pharmacy’s important role in addressing opioid epidemic
Findings might offer relief to those with comorbid headaches and depression
FDA has finalized two guidances to further the efficient development of next-generation sequencing (NGS) technology. "As disease detection technologies rapidly evolve, so too must the FDA's approach to reviewing these new innovations," said FDA Commissioner Scott Gottlieb, MD.
FDA announced Wednesday has permitted marketing of a medical device, the IDx-DR (from IDx LLC), that uses artificial intelligence to detect more than a mild level of diabetic retinopathy in adults with diabetes.
CVS Health is rolling out a new tool to alert its pharmacists to cheaper drug options when they fill patients' prescriptions. CVS Pharmacy's Rx Savings Finder program flags a less expensive therapeutic equivalent, prompting the pharmacist to tell the patient and seek permission to ask their doctor to make the switch.
HB 18-1112 awaits governor’s signature